Prof. Jiewu Zhang 张杰武
Chief Physician, Professor
Department of Head and Neck Surgery (II), Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and surgical treatment of thyroid tumors, including minimally invasive thyroidectomy. Management of laryngeal cancer and oral tumors such as tongue and mandibular cancers, with immediate reconstruction of head and neck tissue defects.
Dr. Zhang is Chief Physician, Professor, and Director of Head and Neck Surgery and Thyroid Surgery at Harbin Medical University Cancer Hospital. Holding a medical doctorate, Dr. Zhang was a senior visiting scholar at the University of Pittsburgh. Research focuses on thyroid tumor surgery, laryngeal cancer, and immune status in cancer patients. Dr. Zhang has published over 30 papers and led provincial research projects.
Professional roles
- Chair, Head and Neck Oncology Professional Committee, Heilongjiang Anti-Cancer Association
- Member, Head and Neck Oncology Professional Committee, China Anti-Cancer Association
- Vice Chair, Otorhinolaryngology-Head and Neck Surgery Professional Committee, Chinese Medical Association Heilongjiang Branch
- Director, Heilongjiang Anti-Cancer Association
Name order: in Chinese the family name comes first (Zhang Jiewu). Papers usually list the name as Jiewu Zhang or Zhang J.
Selected publications
14 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Oncol Rep, 2026 (senior author): OLR1 promotes cell proliferation and invasion while represses apoptosis via regulating histone H3 lysine 18 lactylation‑mediated LEMD1 in papillary thyroid cancer. PubMed 42596831
- Discov Oncol, 2026 (senior author): Transcriptomic identification of key genes influencing m7G modification in thyroid carcinoma and experimental validation. PubMed 42332284
- Discov Oncol, 2025 (senior author): Mendelian randomization analysis reveals causal roles of inflammatory cytokines in thyroid cancer pathogenesis. PubMed 40892159
- Tohoku J Exp Med, 2024 (senior author): The Prognostic Significance of Transient Receptor Potential Canonical 1 and Its Association with Vascular Endothelial Growth Factor Receptor 2 in Papillary Thyroid Carcinoma Patients. PubMed 38925952
- Medicine (Baltimore), 2023 (senior author): Bioinformatics identify the role of chordin-like 1 in thyroid cancer. PubMed 36749222
- Cell Cycle, 2022 (senior author): Circular RNA circ_0000644 promotes papillary thyroid cancer progression via sponging miR-1205 and regulating E2F3 expression. PubMed 34919034
- Cell Death Dis, 2019 (senior author): miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1. PubMed 30814512
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion